Stroke Prevention in Atrial Fibrillation

Why AF makes clots more likely

In a normal heartbeat, blood moves briskly through the heart’s chambers. In AF, sluggish flow, particularly in a small pouch called the left atrial appendage, gives blood time to coagulate. The resulting clots can be ejected into the circulation at any moment, lodging in cerebral arteries and cutting off blood supply. Across South and Southeast Asia, AF prevalence is rising alongside ageing populations and increasing rates of hypertension and diabetes, making this risk highly relevant for residents and expats in markets such as Japan, South Korea, Singapore, and India.

Reducing stroke risk with anticoagulants

The backbone of stroke prevention in atrial fibrillation is long-term anticoagulation, medicines that interfere with the clotting cascade so that dangerous clots are less likely to form. Rivaroxaban is a direct oral anticoagulant (DOAC) used for this purpose; it works by blocking Factor Xa, a key step in clot formation, and does not require routine blood-level monitoring the way older agents do. Managing cardiovascular risk factors such as high blood pressure alongside anticoagulation is equally important; see the heart and blood pressure category for related medicines.

Seek emergency care immediately if you or someone nearby develops sudden face drooping, arm weakness, speech difficulty, or severe headache, these are stroke warning signs that require the fastest possible response.